Oral Cancer (OC) is a subset of head and neck cancer (HNC) with an annual worldwide
incidence of 275,000 cases. OC remains a significant burden worldwide in terms of …

The majority of patients with head and neck squamous cell carcinoma (HNSCC) present
with advanced-stage disease. The current standard of care is surgery followed by adjuvant …

Cancers utilize glycans to evade the immune system via the Sialic acid (Sia)-Siglec (Sialic-
acid-binding immunoglobulin-like lectins) pathway. Specifically, atypical structural forms of …

HNC (head and neck cancer) remains the 6th most common carcinoma worldwide. The
suboptimal survival and toxicities observed with conventional approaches warrant …

Oral squamous cell carcinoma (OSCC) is one of the ten most common causes of cancer
death worldwide. Assessment of molecular changes can help detect and control lesions …

Oral squamous cell carcinoma (OSCC) comprises most of head and neck neoplasms and is
one of the highest-ranking and lethal cancers in Pakistan due to prevailing mouth habits …

BACKGROUND The combination of cisplatin, 5‐fluorouracil, and cetuximab is a standard
treatment for patients with recurrent/metastatic head and neck cancer, with a high rate of …

Background: HER-2/neu is a member of the human epidermal growth factor (HER) family of
transmembrane tyrosine kinases, which is significantly associated with the pathogenesis of …

Background: Human epidermal growth factor receptor 2 (HER2)/neuprotooncogene (neu) is
a proven molecular prognostic marker in breast, ovarian, gastric, and ovarian cancers. In …

Purpose Her2 (ErbB2) transforms cells when overexpressed and is an important therapeutic
target in breast cancer. Contrary to breast cancer, studies on Her2 overexpression and gene …